The Friends of NPACE Podcast | Episode 2: Clinicians, What Are We Missing in Obesity? Featuring Christine Kessler & Angie Golden

In the second episode of the Friends of NPACE Podcast Executive Director Terri Schmitt is joined by Christine Kessler, CNS, ACNP, ANP-C, BC-ADM, FAANP & Angela Golden, DNP, FNP-C, FAANP, FOMA to discuss obesity management in primary care. This discussion is aimed at helping educate HCPs on pathophysiology, interventions, medications, and barriers to care for this endocrine disorder to promote advancement of care for patients nationwide. 

Credits: 0.75 contact hours; 0.25 are pharmacology 

Christine Kessler, MN, ANP, CNS, BC-ADM, CDTC, FAANP

Founder and Clinical Consultant

Metabolic Medicine Associates

Christine Kessler is an award-winning nurse practitioner, national/international speaker, prolific author, and clinical consultant specializing in General Endocrinology, Obesity, and Metabolic Medicine. During her 48 years of nursing (40 years in advanced practice) she has held diverse roles in management, research, academia (as assistant professor undergraduate and graduate nursing), and especially clinical practice; the latter as a critical care clinical specialist, an acute care nurse practitioner (as hospitalist & intensivist) and adult endocrinology nurse practitioner.

After 15 years as the senior nurse practitioner at a large hospital Department of Endocrinology and Metabolic Medicine, Christine now focuses on providing diabetes and general endocrine services, as well as weight-loss management, in rural Virginia. Christine has received numerous top medical clinical practice and patient satisfaction awards, including the Coin of Excellence personally awarded by the Surgeon General for having the highest patient satisfaction rating of all health care providers in the Army WORLDWIDE. Christine is a Fellow of the American Association of Nurse Practitioners.

Angela Golden, DNP, FNP-C, FAANP

Owner and Provider

NP From Home, LLC

Dr. Angela Golden, is a current fellow and past president of the American Association of Nurse Practitioners. Her tenure as the president of the AANP gives her a unique and overarching perspective of the multifunctional role of the Nurse Practitioner. For the past 26 years, Angie has had her own practice—NP from Home, LLC—where she provides clinical services in a family practice and for the past 7 years a subspecialty obesity practice, NP Obesity Treatment Clinic

Angie has a great deal of experience in leadership positions and clinical practice. She has authored peer-reviewed articles and book chapters covering a range of health topics including health policy. She has presented nationally and internationally with an emphasis on health policy, leadership, and various clinical topics

The overall goal is to help educate HCPs about the current issues related to obesity in order to promote advancement of care for patients nationwide by increasing the number of health care providers that can:

(1) accurately screen and appropriately apply differential diagnosis for earlier diagnosis and timely intervention of obesity and comorbidities 

(2) effectively assess and manage obesity as a chronic, serious and progressive disease warranting early intervention and long-term care to minimize related comorbidities, like diabetes and cardiovascular disease across diverse patient populations 

(3) comprehensively manage obesity with both behavior and lifestyle modifications as well as the inclusion of pharmacotherapy, highlighting the safety and efficacy of available marketplace treatment option 

(4) address disparity gaps within practice while effectively integrating more cultural sensitivity to all patient visits 

(5) implement person-centered methods for evidence-based obesity management in the primary care setting

Obtain Your Credits

To earn credits for this activity, you must complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 0.50 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.


Contributing faculty, Christine Kessler,CNS, ACNP, ANP-C, BC-ADM, FAANP have disclosed: 

Novo Nordisk, Promotional speaker ad boards, Obesity & T2DM

Acella, Promotional speaker ad boards, Thyroid, NP Thyroid

Contributing faculty, Angela Golden, DNP, FNP-C, FAANP, FOMA  have disclosed: Novo Nordisk

Novo NordiskObesity, Promotional speaker Advisory board

Acella, Thyroid, Advisory board Promotional speaker 

Gelesis, Thyroid, Advisory board

Currax, Obesity, Advisory board Promotional speaker

Lilly, Obesity and Sleep Apnea, Advisory board

WWObesity, Advisory board

SetPoint, Obesity, Advisor


All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 


The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

This session is supported by an educational grant from Eli Lilly. 

Components visible upon registration.